Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 55INDUSTRY 10OTHER_GOV 3NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 3Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Sarcopenia 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1

Interventions

Pemetrexed 13Cisplatin 12Carboplatin 12Drug Therapy 10Gemcitabine 8Gefitinib 8Docetaxel 8camrelizumab 5apatinib 5Radiotherapy 5Paclitaxel 5Nivolumab 5Irinotecan 5Erlotinib Hydrochloride 5Endostatins 5tislelizumab 4pembrolizumab 4endostar protein 4Simvastatin 4Bevacizumab 4anlotinib 3Platinum Compounds 3Immune Checkpoint Inhibitors 3Etoposide 3toripalimab 2surufatinib 2olaparib 2durvalumab 2atezolizumab 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Immune Checkpoint Inhibitors × Thoracic × Clear all
NCT07192926 2026-02-20

SARCO-CTI

Ankara Etlik City Hospital

Completed
131 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT05348668 2026-01-07

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

Anhui Provincial Hospital

Phase 2 Completed
78 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04613804 2020-11-03

Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy

Fujian Cancer Hospital

Phase 2 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡